Company page

Vistagen Therapeutics, Inc.

Vistagen Therapeutics, Inc. (ticker: VTGN) is a public company based in the United States, focusing on developing treatments for mental health conditions. The company has a market capitalization of approximately $9.29 million. Vistagen is dedicated to advancing its innovative therapies to address unmet needs in the mental health space.